Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC.

Papavassiliou, Kostas A; Marinos, Georgios; Papavassiliou, Athanasios G

Papavassiliou, Kostas A; Marinos, Georgios; Papavassiliou, Athanasios G.

Afiliação

Papavassiliou KA; First University Department of Respiratory Medicine, Medical School, "Sotiria" Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Marinos G; Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Papavassiliou AG; Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Cancers (Basel) ; 15(2)2023 Jan 06.

Article em En | MEDLINE | ID: mdl-36672335

Palavras-chave

NSCLC; STAT3; drug resistance; immune checkpoint inhibitors

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google